Literature DB >> 3186704

Gene transfer from targeted liposomes to specific lymphoid cells by electroporation.

P Machy1, F Lewis, L McMillan, Z L Jonak.   

Abstract

Large unilamellar liposomes, coated with protein A and encapsulating the gene that confers resistance to mycophenolic acid, were used as a model system to demonstrate gene transfer into specific lymphoid cells. Protein A, which selectively recognizes mouse IgG2a antibodies, was coupled to liposomes to target them specifically to defined cell types coated with IgG2a antibody. Protein A-coated liposomes bound human B lymphoblastoid cells preincubated with a mouse IgG2a anti-HLA monoclonal antibody but failed to adhere to cells challenged with an irrelevant (anti-H-2) antibody of the same isotype or to cells incubated in the absence of antibody. Transfection of target cells bound to protein A-coated liposomes was achieved by electroporation. This step was essential since only electroporated cells survived in a selective medium containing mycophenolic acid. Transfection efficiency with electroporation and targeted liposomes was as efficient as conventional procedures that used unencapsulated plasmids free in solution but, in the latter case, cell selectivity is not possible. This technique provides a methodology for introducing defined biological macromolecules into specific cell types.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3186704      PMCID: PMC282347          DOI: 10.1073/pnas.85.21.8027

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  50 in total

1.  Optimal conditions for uptake of exogenous DNA by Chinese hamster lung cells deficient in hypoxanthine-guanine phosphoribosyltransferase.

Authors:  F E Farber; J L Melnick; J S Butel
Journal:  Biochim Biophys Acta       Date:  1975-05-16

2.  Splicing and the formation of stable RNA.

Authors:  D H Hamer; P Leder
Journal:  Cell       Date:  1979-12       Impact factor: 41.582

3.  High-frequency transfer of cloned herpes simplex virus type 1 sequences to mammalian cells by protoplast fusion.

Authors:  R M Sandri-Goldin; A L Goldin; M Levine; J C Glorioso
Journal:  Mol Cell Biol       Date:  1981-08       Impact factor: 4.272

4.  Synthesis of rabbit beta-globin in cultured monkey kidney cells following infection with a SV40 beta-globin recombinant genome.

Authors:  R C Mulligan; B H Howard; P Berg
Journal:  Nature       Date:  1979-01-11       Impact factor: 49.962

Review 5.  Use of staphylococcal protein A as an immunological reagent.

Authors:  J W Goding
Journal:  J Immunol Methods       Date:  1978       Impact factor: 2.303

Review 6.  Biologic activity of isolated viral nucleic acids.

Authors:  J S Pagano
Journal:  Prog Med Virol       Date:  1970

7.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

8.  Methods for micromanipulation of human somatic cells in culture.

Authors:  E G Diacumakos
Journal:  Methods Cell Biol       Date:  1973       Impact factor: 1.441

9.  Lipid vesicles as carriers for introducing biologically active materials into cells.

Authors:  G Poste; D Papahadjopoulos; W J Vail
Journal:  Methods Cell Biol       Date:  1976       Impact factor: 1.441

10.  Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation.

Authors:  F Szoka; D Papahadjopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

View more
  2 in total

1.  Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA.

Authors:  J P Behr; B Demeneix; J P Loeffler; J Perez-Mutul
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

2.  Novel liposomal formulation for targeted gene delivery.

Authors:  Véronique Rivest; Alix Phivilay; Carl Julien; Sandra Bélanger; Cyntia Tremblay; Vincent Emond; Frédéric Calon
Journal:  Pharm Res       Date:  2007-03-24       Impact factor: 4.580

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.